DRL Of India Freed Of U.S. Injunction Against Allegra Generic
This article was originally published in PharmAsia News
Executive Summary
India's Dr. Reddy's Laboratories has been freed of a U.S. court injunction against marketing a generic version of Allegra D24 (fexofenadine)